Butterfly Network, Inc.

Butterfly Network, Inc.(BFLY)股票分析

$7.250

-0.554 (-7.64%)收盘时

Loading chart…
最高
7.902
开盘
7.800
成交量加权均价
7.46
成交量
4.57M
市值
183.27M
最低
7.220
成交额
34.08M
企业价值/息税折旧摊销前利润(TTM)
-50.31

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software.

AI 分析 of Butterfly Network, Inc. (BFLY)

持有

Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.

估值指标

Butterfly Network, Inc.(BFLY)当前预期市盈率为 0.00,5 年平均预期市盈率为 -5.62。

预期市盈率

高估
5 年均值 P/E
-5.62
当前P/E
0.00
高估
-1.71
低估
-9.53

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
-10.54
当前EV/EBITDA
-50.31
高估
1.83
低估
-22.91

预期市销率

高估
5 年均值 P/S
7.72
当前P/S
13.87
高估
12.51
低估
2.94

Alphio AI 对 BFLY 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%BFLY

$4.30

情景价格

基

基准

基准 · 50%BFLY

$3.65

情景价格

悲

悲观

悲观 · 25%BFLY

$3.17

情景价格

持有 BFLY 的大户

F

Fosun International Holdings Ltd.

+ 持有BFLY

-6.70%

3个月收益率

事件时间线

2026-10-13 (ET)

08:30:00

VCOM and Butterfly Network Form Long-Term Alliance

2026-10-06 (ET)

16:30:00

Bridge Neurotech and Butterfly Network Sign R&D Agreement

2026-10-05 (ET)

08:30:00

Butterfly Network Appoints Mike Noonen to Board of Directors

2026-10-01 (ET)

08:30:00

Mendaera and Butterfly Network Launch Focalist System

2026-09-22 (ET)

12:30:00

Butterfly Network Shares Rise 17.7% to $9.58

资讯

BFLY 常见问题 —— 由 Alphio AI 解答

Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software. It operates in the Healthcare sector (X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPA industry).

Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易